Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

SurModics Inc Raises FY 2014 Revenue Guidance; Lowers FY 2014 EPS Guidance


Tuesday, 5 Nov 2013 04:15pm EST 

SurModics Inc announced that for fiscal 2014, it expects GAAP revenue to be in the range of $58.0 to $62.0 million. SurModics anticipates diluted GAAP earnings to be in the range of $0.80 to $0.92 per share. The fiscal 2014 earnings per share guidance includes an increase of approximately 20% in research and development investment over fiscal 2013 levels primarily related to drug coated balloon activities. According to I/B/E/S Estimates, analysts are expecting the Company to report revenues of $62.5 million and EPS of $0.93 for fiscal 2014. 

Latest Key Developments in Specialty

Company Quote

21.06
0.09 +0.43%
20 Oct 2014